CMT Research Foundation invests in research project to develop treatments for CMTs
The rare, peripheral neuropathy disease affects nearly three million people globally
Read More
Tag: Charcot-Marie-tooth disease
CMT Research Foundation funds study investigating treatment for CMT1X disease
X-linked Charcot-Marie-Tooth is the second most common form of the rare peripheral neuropathy disease
Read More
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
